Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
Inflamm Bowel Dis
; 27(4): 585-589, 2021 03 15.
Article
in English
| MEDLINE | ID: covidwho-978598
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Piperidines
/
Pyrimidines
/
Inflammatory Bowel Diseases
/
Protein Kinase Inhibitors
/
COVID-19
Type of study:
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Language:
English
Journal:
Inflamm Bowel Dis
Journal subject:
Gastroenterology
Year:
2021
Document Type:
Article
Affiliation country:
Ibd
Similar
MEDLINE
...
LILACS
LIS